United States · FDA National Drug Code directory
Aleve Headache Pain
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0280-0112_31baf777-c806-21ea-e063-6394a90abbd8
- Product NDC
- 0280-0112
- Form
- TABLET
- Composition / generic term
- NAPROXEN SODIUM
- Labeler
- Bayer HealthCare LLC.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20230404
- Source listing expiry
- 20261231
Source-listed ingredients
- NAPROXEN SODIUM — 220 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE in 1 CARTON (0280-0112-01) / 175 TABLET in 1 BOTTLE · 0280-0112-01
- 1 BOTTLE in 1 CARTON (0280-0112-02) / 24 TABLET in 1 BOTTLE · 0280-0112-02
- 1 BOTTLE in 1 CARTON (0280-0112-03) / 50 TABLET in 1 BOTTLE · 0280-0112-03
- 1 BOTTLE in 1 CARTON (0280-0112-04) / 90 TABLET in 1 BOTTLE · 0280-0112-04
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →